Clinical Trials
12 trialsNCT06015061 2023-08-29
Prediction and Evaluation of Anlotinib Treatment Response Using Contrast Enhanced Ultrasound PPGL Patients
Peking Union Medical College Hospital
Unknown
NCT05885399 2023-06-02
The Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic Treatment
Peking Union Medical College Hospital
Phase 2 Unknown
NCT03475953 2023-03-03
REGOMUNE
Institut Bergonié
Phase 1/2 Unknown
NCT00986661 2022-11-02
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Provectus Pharmaceuticals
Phase 1 Unknown
NCT03896958 2020-12-04
PIONEER
SpeciCare
Unknown
NCT03881306 2020-08-20
DEBOXA for Inoperable NET Liver Metastases
Xiangya Hospital of Central South University
Phase 1/2 Unknown
NCT04066322 2019-09-24
RMPanNET
Fudan University
Unknown
NCT03863106 2019-03-05
LyREMeNet
Hospices Civils de Lyon
Unknown
NCT01731925 2017-01-31
SUNLAND
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2 Unknown
NCT02409849 2015-04-07
Octreotide LAR as Maintenance Treatment for Patients With NEC
Peking University
Phase 2 Unknown
NCT00454376 2013-10-29
Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors
National Cancer Institute (NCI)
Unknown
NCT01201096 2010-09-23
NEO-LEBE
University of Jena
Unknown